儿童钆基对比剂安全性:系统综述与Meta分析
该系统综述与Meta分析评估儿童和青少年接受增强MRI时钆基对比剂的安全性,纳入32项研究共112 760次检查分析不良反应,8项研究共4895例患者分析肾源性系统性纤维化,6项研究共787次检查分析脑内钆沉积。急性生理性不良反应率为0.25%,过敏性样反应为0.13%,迟发性不良反应为0.04%,无肾源性系统性纤维化病例报告;齿状核-脑桥信号强度比与钆基对比剂给药次数的关联受对比剂构型影响,线性和大环状对比剂之间存在交互效应。
要点
- 儿童增强MRI中钆基对比剂急性生理性不良反应率0.25%,过敏性样反应0.13%,迟发性0.04%。
- 4895例患者中未报告肾源性系统性纤维化病例。
- 齿状核-脑桥信号强度比与给药次数的关联在线性与大环状对比剂间存在交互效应(交互项回归系数0.004,P=0.002)。
核心结论
- 儿童钆基对比剂不良反应发生率低,未报告肾源性系统性纤维化病例;线性与大环状对比剂在齿状核-脑桥信号强度比与给药次数关联中的回归系数不同。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE/PubMed、Embase、Web of Science和Cochrane图书馆截至2023年11月22日的文献;32项研究共112 760次检查分析钆基对比剂相关不良反应,8项研究共4895例患者分析肾源性系统性纤维化,6项研究共787次检查分析脑内钆沉积;脑内钆沉积采用线性混合效应模型评估齿状核-脑桥信号强度比与钆基对比剂给药次数的个体水平关联,并纳入对比剂构型(线性 vs 大环状)的交互效应。
关键影像表现/征象
- 脑内钆沉积分析显示齿状核-脑桥信号强度比与钆基对比剂给药次数的关联受对比剂构型影响,交互项回归系数0.004(95%CI:0.002,0.007;P=0.002)。
- 大环状对比剂的回归系数为0.0004(95%CI:-0.002,0.003),线性对比剂为0.004(95%CI:0.003,0.006)。
诊断标准与关键数值
- 急性钆基对比剂相关不良反应率:生理性反应0.25%(95%CI:0.11,0.53),过敏性样反应0.13%(95%CI:0.08,0.20)。
- 迟发性不良反应率为0.04%(95%CI:0.02,0.07)。
- 肾源性系统性纤维化发生率为0例(4895例患者中0例)。
- 齿状核-脑桥信号强度比与给药次数关联的交互项回归系数为0.004(95%CI:0.002,0.007;P=0.002),大环状对比剂回归系数0.0004(95%CI:-0.002,0.003),线性对比剂回归系数0.004(95%CI:0.003,0.006)。
临床应用与阅片要点
- 儿童增强MRI中钆基对比剂急性生理性不良反应率0.25%、过敏性样反应0.13%、迟发性不良反应0.04%,可据此向临床沟通安全性信息。
- 4895例患者中未报告肾源性系统性纤维化病例。
- 分析脑内钆沉积时需区分对比剂构型:齿状核-脑桥信号强度比与给药次数的关联在线性与大环状对比剂间存在交互效应(交互项回归系数0.004,P=0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Pediatric safety concerns regarding gadolinium-based contrast agents (GBCAs) used in contrast-enhanced MRI examinations persist. Purpose To conduct a systematic review and meta-analysis to evaluate the safety of GBCAs in children and adolescents undergoing contrast-enhanced MRI examinations, focusing on GBCA-associated adverse drug reaction (ADR), nephrogenic systemic fibrosis (NSF), and gadolinium deposition in the brain. Materials and Methods MEDLINE/PubMed, Embase, Web of Science, and the Cochrane library were searched for articles published up to November 22, 2023. Articles reporting the incidence of GBCA-associated ADRs with information on GBCA type were meta-analytically pooled. The incidence of NSF was systematically reviewed. For gadolinium deposition in the brain, a linear mixed-effects model was used to assess the individual-level association between the dentate nucleus (DN)-to-pons signal intensity (SI) ratios and the number of GBCA administrations, including the interaction effect of GBCA configuration (linear vs macrocyclic). Results Thirty-two studies covering 112 760 examinations for GBCA-associated ADRs, eight studies covering 4895 patients for NSF, and six studies covering 787 examinations for brain gadolinium deposition were included. The acute GBCA-associated ADR rate was 0.25% for physiologic (95% CI: 0.11, 0.53) and 0.13% for allergic-like (95% CI: 0.08, 0.20) reactions. The delayed ADR rate was 0.04% (95% CI: 0.02, 0.07). No patients with NSF were reported (0 of 4895 patients). There was an interaction effect of GBCA category (macrocyclic or linear) on the association between DN-to-pons SI ratios and the number of GBCA administrations (regression coefficient of interaction term, 0.004; 95% CI: 0.002, 0.007; P = .002), with the regression coefficient being 0.0004 for macrocyclic (95% CI: -0.002, 0.003) and 0.004 for linear (95% CI: 0.003, 0.006) agents. Conclusion Adverse reactions to GBCA in children occurred at a low rate, with no patients with NSF reported. The regression coefficient differed between linear and macrocyclic agents when examining their effect on the association between DN-to-pons SI ratios and the number of GBCA administrations. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by McInnes in this issue.
引用
- Yu OJ, Kim PH, Yoon HM, et al. Safety of Gadolinium-based Contrast Agents in Children: A Systematic Review and Meta-Analysis. Radiology. 2025. PMID: 40728401. doi:10.1148/radiol.241224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。